We all are aware that Biomarker and Companion Diagnostics on a way are progressively utilized to enhance patient diagnosis and monitor healing retorts. By using biomarkers, medics can stipulate adequate treatments to their patients. While treating a particular patient using biomarkers, medics can monitor the treatment mechanism for the diseases and measures from available samples like body fluids.
Improved biomarkers are very much needed to enhance diagnosis, monitor movements, direct molecularly targeted treatment and healing response covering a huge spectrum of diseases. Advancements in techniques and patterns now help the construction of a comprehensive biomarker channel from the most fundamental segments:
- Prospect Discovery
- Verification and Validation Biomarker
- Qualification
- Research Analysis Optimization
- Management and Execution
The overall analyses and discovery of biomarkers should help in improving and increasing the effectiveness of biomarker development. One of the foremost causes of death these years is cancer which is growing rapidly. There is no surprise that there is no research and advancement to invent new ways to detect and treat the disease. The area that is comprehensively researched is companion diagnostics. They have been working on tests that can be utilized to determine which patients are most likely to respond positively to a particular disease in cancer. Even in the early invention days, companion diagnostics is having a positive effect on all the results found in cancer patients.
Taking these points into focus, MarketsandMarkets has decided to launch its 4th Annual Biomarker and Companion Diagnostics Conference UK/EU to be scheduled on 6th – 7th October 2022 in London. Through this companion diagnostics biomarker conference, you would address the gaps between early-stage biomarker development and the commercialization stage of biomarkers.
You will find all the solutions that uncover the key challenges in biomarker research. Be a part of the 4th Annual MarketsandMarkets Biomarker and Companion Diagnostics Conference UK/EU and examine the right information for the analysis of proteomic, genomics, cellular biomarker.
Enquiry More About Conference @ https://events.marketsandmarkets.com/4th-annual-marketsandmarkets-biomarker-and-companion-diagnostics-conference-uk-eu/enquiry
Key Highlights
- Clinical biomarker identification and qualification
- Biomarkers and personalized medicine
- Assay development and validation
- NGS and novel technologies in biomarker discovery
- Commercialization of biomarkers in therapeutic and CDx applications
Grab the opportunity to interact with the C Level experts in the industry, like Ginkgo bioworks Inc., Corbus Pharmaceuticals, SANOFI, 2seventy bio, and many more. Witness the latest insights, case studies and technologies enhancing your predictive biomarker discovery, to support next generation CDx development, informed clinical decisions, regulatory approval & a robust go-to market strategy for a breakthrough therapy.
You can also avail for customize sponsorship package the way you want.
Book your slot now by registering online or writing to us at events@marketsandmarkets.com for more details.
